What is AMGN's current stock price?

As of now, AMGN is trading at $318.65, with a daily change of +0.47%.

What are AMGN stock strengths?

AMGN strengths include Outperform the market, Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued, .

What are the risks associated with AMGN stock?

AMGN Key risk is its Low Risk Level, .

What is AMGN next earnings date?

AMGN next earnings report is scheduled for Apr 30, 2025.

What is AMGN's current stock rating?

AMGN's current stock rating is Sell.

Should I buy AMGN stock right now?

Based on the current rating of Sell, it is advisable to consider Sell as your next step with AMGN stock.

Is AMGN a Strong Buy right now?

AMGN's current stock rating is Sell, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for AMGN?

A 'Strong Buy' rating for AMGN indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for AMGN?

A 'Strong Sell' rating for AMGN suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence AMGN's stock rating?

AMGN's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Amgen (AMGN) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

AMGN

Amgen

$318.65

+$1.48 | +0.47%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Open

$ 317.56

MKT CAP

$ 171.28B

High

$ 319.31

VOL

$ 2.42M

Low

$ 315.18

AVG VOL

$ 3.21M

Chart

307.81

258.78

319.29

276.21

1year

6month

3month

1month

AMGN Latest Headlines +

Amgen Rises Almost 22% YTD: Should You Buy Hold or Sell the Stock?. AMGNs consistent top-line growth an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock for now.

Today

Activity

Momentum

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study. New late-stage study data shows that treatment with Amgens Uplizna for a year improves disease symptoms in patients with generalized myasthenia gravis.

Mon Mar 17, 2025

Activity

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It. Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus it is worth knowing the facts that could determine the stocks prospects.

Mon Mar 17, 2025

Activity

Notable Friday Option Activity: AMGN LLY CRK. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Amgen Inc (Symbol: AMGN) where a total of 19873 contracts have traded so far representing approximately 2.0 million underlying shares. That amounts to about 64.6% of

Fri Mar 14, 2025

Momentum

Amgens Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year. On Thursday ) announced new data from the Phase 3 MINT trial of Uplizna(inebilizumab-cdon) for adult patients with generalized myasthenia gravis (gMG) a chronic autoimmune disease that causes muscle weakness.It affects the muscles used for breathing swallowing facial .The results demonstrated the durable and sustained efficacy of Uplizna in patients with acetylcholine receptor autoantibody-positive (A

Thu Mar 13, 2025

Activity

Potential

Amgens Options: A Look at What the Big Money is Thinking. Deep-pocketed investors have adopted a ish approach towards Amgen (NASDAQ:) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in AMGN usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga'.s opti

Wed Mar 12, 2025

Activity

Potential

CVKD: Collaborating with Abbott for Pivotal Phase 3 Trial. By Business UpdateCollaboration Agreement with Abbott for Phase 3 TECH-LVAD TrialOn March 4 2025 Cadrenal Therapeutics Inc. (NASDAQ:CVKD) announced a collaboration agreement with Abbott for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial. In August 2024 Cadrenal had announced it was in discussions with Abbott about the pivotal Phase 3 trial of tecarfarin for patients wit

Fri Mar 7, 2025

Activity

Amgen Reaches Analyst Target Price. In recent trading shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $317.58 changing hands for $317.82/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on valuatio

Fri Mar 7, 2025

Potential

Rating

Amgen begins late-stage trials for obesity therapy.

Wed Mar 5, 2025

Activity

Amgen starts two critical late-stage trials for weight loss drug MariTide. MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.

Wed Mar 5, 2025

Activity

Explore our AMGN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AMGN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AMGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

AMGN

Amgen

$318.65

+$1.48 | +0.47%

Chart

307.81

258.78

319.29

276.21

1year

6month

3month

1month

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AMGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AMGN Stock Analysis for the Last 90 Days

AMGN Risk Level

AMGN Analysts Opinion

AMGN Street Consensus

AMGN Performance Sentiment

Technical Price Levels

AMGN Financial Health

AMGN Fair Price vs Current Price

Explore our AMGN Stock insights

Receive our AMGN Daily Alerts

AMGN Stock Analysis for the Last 90 Days

AMGN Street Consensus

Technical Price Levels

AMGN Fair Price vs Current Price

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

Receive our AMGN Daily Alerts